These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [About 40 cases of polyradiculoneuritis. Landry-Guillain-Barré-Strohl's syndrome (author's transl)]. de Morsier G Acta Neurol Belg; 1973; 73(4):220-8. PubMed ID: 4770125 [No Abstract] [Full Text] [Related]
25. Transplantation for the millennium: attaining tolerance in our time--the Holy Grail. Helderman JH; Goral S Semin Nephrol; 2000 Jan; 20(1):83-6. PubMed ID: 10651221 [TBL] [Abstract][Full Text] [Related]
26. Perspectives of immunosuppression. Balner H Transplant Proc; 1971 Mar; 3(1):949-52. PubMed ID: 4941149 [No Abstract] [Full Text] [Related]
27. [Immunosuppressive therapy]. Schumacher K; Gross R Internist (Berl); 1984 Jan; 25(1):51-9. PubMed ID: 6370894 [No Abstract] [Full Text] [Related]
28. [Dynamics of changes in the subpopulations of rosette-forming B-lymphocytes during immunosuppressive therapy]. Voĭlokova RIa; Zaretskaia IuM; Rasulova TKh; Levitskiĭ ER Probl Gematol Pereliv Krovi; 1980 May; 25(5):12-5. PubMed ID: 6995970 [No Abstract] [Full Text] [Related]
29. [The clinical aspects and the treatment of acute inflammatory or serous polyneuritis (syndrome of Landry, Guillain, Barré)]. Schaltenbrand G; Bammer H Rev Neurol (Paris); 1966 Oct; 115(4):783-810. PubMed ID: 5982597 [No Abstract] [Full Text] [Related]
30. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats. Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900 [No Abstract] [Full Text] [Related]
31. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide. Lin Y; Waer M Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224 [No Abstract] [Full Text] [Related]
32. [Administration of encephalitogenic basic protein in the diagnosis of multiple sclerosis and Guillain-Barré syndrome]. Wajgt A; Wiktorowicz K; Torliński L Neurol Neurochir Pol; 1974; 8(5):653-62. PubMed ID: 4139672 [No Abstract] [Full Text] [Related]
35. The influence of immunosuppression on the development of BK virus nephropathy-- does it matter? Beimler J; Sommerer C; Zeier M Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii66-viii71. PubMed ID: 17890267 [TBL] [Abstract][Full Text] [Related]
36. Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy. Bishop GA; McCaughan GW Liver Transpl; 2001 Mar; 7(3):161-72. PubMed ID: 11244155 [TBL] [Abstract][Full Text] [Related]
37. [Advances of immunobiology]. Santiago Delpín EA Bol Asoc Med P R; 1995; 87(5-6):120. PubMed ID: 8573253 [No Abstract] [Full Text] [Related]
40. The Guillain-Barré syndrome as a complication of the postperfusion syndrome. Costantino T; Weintraub A Am Heart J; 1972 Nov; 84(5):678-80. PubMed ID: 4344802 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]